Group One Trading
ARDS

Group One Trading’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Group One Trading’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,700
Closed -$2.1K – 8412
2023
Q1 		$2.1K Buy
6,700
+1,400
+26% +$1.02K ﹤0.01% 6601
2022
Q4 		$6.25K Buy
+5,300
New +$5.12K ﹤0.01% 6239

Other funds holding ARDS

WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Group One Trading's ARDS Position: Q3 2023 in Review

Group One Trading sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 2,337 shares — an estimated $514 sold.

Group One Trading first reported a position in ARDS in Q1 2022 and held it in 6 quarters. The position peaked at $48K in Q1 2022. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

  • Group One Trading reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 2,337 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $514.
  • Group One Trading first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Group One Trading's Aridis Pharmaceuticals Inc. Common Stock position peaked at $48K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.